Lawyers in the turf war over five competing AMP class actions have agreed to a temporary peace accord after the battleground edged close to the realm of the absurd, with a threatened anti-anti suit injunction being met with calls for an anti-anti-anti suit injunction.
The US securities regulator is reportedly looking into Facebook’s disclosures to investors about the harvesting of user data by political research firm Cambridge Analytica, as the company faces the threat of a privacy class action in Australia over the data debacle.
Cash Converters has been asked to produce data on individuals that it provided payday loans to in Queensland in a class action alleging it charged a brokerage fee to borrowers for services they never received.
A Sydney lawyer accused in a class action of conspiring with notorious conman Peter Foster in a fraudulent sports betting scheme that left investors $29 million out of pocket was taken in by Foster’s “psychological brilliance”, her barrister told a court Thursday.
Australia is not the haven for class actions that critics have claimed, according to a new report that shoots down the notion that the country is just behind litigation-happy US when it comes to targeting corporations in court.
The litigation funder behind the Federal Court’s precedential ruling that established the first common fund order in an Australian class action agreed to cuts its rates as part of negotiations that resulted in the $132.5 million settlement of the class action against QBE Insurance.
The law firm behind one of four AMP class actions in Federal Court might call for an anti-anti-suit injunction in response to a threat by a NSW Supreme Court judge to block the actions from proceeding in favour of the lone case filed against the wealth manager in state court.
Facing cross-examination over the law firm’s bid to add fraud and deceit claims to a class action against Fitch Ratings, a Squire Patton Boggs lawyer exchanged fire with a barrister for the ratings agency, saying Fitch was having a regular “whinge” about discovery and “no” she would not take the comment back.
The judge overseeing a class action against Johnson & Johnson over allegedly defective vaginal mesh products has asked the applicants to weigh in on a recent UK High Court ruling that found there must be an abnormal risk in order for a product to be considered defective.
A trial is set to kick off at the end of July in two class actions brought on behalf of holders of debentures who allege they suffered losses due to Australian Executor Trustees’ mismanagement of debenture issuer Provident Capital.